199 related articles for article (PubMed ID: 10441143)
1. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies.
Brix LA; Barnett AC; Duggleby RG; Leggett B; McManus ME
Biochemistry; 1999 Aug; 38(32):10474-9. PubMed ID: 10441143
[TBL] [Abstract][Full Text] [Related]
2. Role of glutamic acid 216 in cytochrome P450 2D6 substrate binding and catalysis.
Guengerich FP; Hanna IH; Martin MV; Gillam EM
Biochemistry; 2003 Feb; 42(5):1245-53. PubMed ID: 12564927
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.
Dajani R; Hood AM; Coughtrie MW
Mol Pharmacol; 1998 Dec; 54(6):942-8. PubMed ID: 9855620
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of human aryl sulphotransferases.
Brix LA; Duggleby RG; Gaedigk A; McManus ME
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):337-43. PubMed ID: 9882633
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutagenesis of the substrate-binding cleft of human estrogen sulfotransferase.
Hempel N; Barnett AC; Bolton-Grob RM; Liyou NE; McManus ME
Biochem Biophys Res Commun; 2000 Sep; 276(1):224-30. PubMed ID: 11006110
[TBL] [Abstract][Full Text] [Related]
6. Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity.
Toth D; Dudas B; Miteva MA; Balog E
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069221
[TBL] [Abstract][Full Text] [Related]
7. Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3.
Barnett AC; Tsvetanov S; Gamage N; Martin JL; Duggleby RG; McManus ME
J Biol Chem; 2004 Apr; 279(18):18799-805. PubMed ID: 14871892
[TBL] [Abstract][Full Text] [Related]
8. Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein.
Munagala NR; Wang CC
Biochemistry; 1998 Nov; 37(47):16612-9. PubMed ID: 9843428
[TBL] [Abstract][Full Text] [Related]
9. Kinetic properties of human dopamine sulfotransferase (SULT1A3) expressed in prokaryotic and eukaryotic systems: comparison with the recombinant enzyme purified from Escherichia coli.
Dajani R; Sharp S; Graham S; Bethell SS; Cooke RM; Jamieson DJ; Coughtrie MW
Protein Expr Purif; 1999 Jun; 16(1):11-8. PubMed ID: 10336855
[TBL] [Abstract][Full Text] [Related]
10. The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA binding protein.
Hempel N; Wang H; LeCluyse EL; McManus ME; Negishi M
Mol Pharmacol; 2004 Dec; 66(6):1690-701. PubMed ID: 15383623
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of human catecholamine sulfotransferase.
Bidwell LM; McManus ME; Gaedigk A; Kakuta Y; Negishi M; Pedersen L; Martin JL
J Mol Biol; 1999 Oct; 293(3):521-30. PubMed ID: 10543947
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of SULT1A2 and SULT1A1 *3: insights into the substrate inhibition and the role of Tyr149 in SULT1A2.
Lu J; Li H; Zhang J; Li M; Liu MY; An X; Liu MC; Chang W
Biochem Biophys Res Commun; 2010 May; 396(2):429-34. PubMed ID: 20417180
[TBL] [Abstract][Full Text] [Related]
13. Dimerization is responsible for the structural stability of human sulfotransferase 1A1.
Lu LY; Chiang HP; Chen WT; Yang YS
Drug Metab Dispos; 2009 May; 37(5):1083-8. PubMed ID: 19237513
[TBL] [Abstract][Full Text] [Related]
14. Sulfation of ritodrine by the human cytosolic sulfotransferases (SULTs): Effects of SULT1A3 genetic polymorphism.
Hui Y; Liu MC
Eur J Pharmacol; 2015 Aug; 761():125-9. PubMed ID: 25941087
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl residues in the active site of human phenol sulfotransferase (SULT1A1).
Chen G; Rabjohn PA; York JL; Wooldridge C; Zhang D; Falany CN; Radominska-Pandya A
Biochemistry; 2000 Dec; 39(51):16000-7. PubMed ID: 11123927
[TBL] [Abstract][Full Text] [Related]
16. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation.
Nagar S; Walther S; Blanchard RL
Mol Pharmacol; 2006 Jun; 69(6):2084-92. PubMed ID: 16517757
[TBL] [Abstract][Full Text] [Related]
17. Amino acid residue 247 in canine sulphotransferase SULT1D1: a new determinant of substrate selectivity.
Tsoi C; Widersten M; Morgenstern R; Swedmark S
Biochem J; 2004 Mar; 378(Pt 2):687-92. PubMed ID: 14614767
[TBL] [Abstract][Full Text] [Related]
18. Induction of human sulfotransferase 1A3 (SULT1A3) by glucocorticoids.
Bian HS; Ngo SY; Tan W; Wong CH; Boelsterli UA; Tan TM
Life Sci; 2007 Dec; 81(25-26):1659-67. PubMed ID: 17963788
[TBL] [Abstract][Full Text] [Related]
19. Effects of substitution of tryptophan 412 in the substrate activation pathway of yeast pyruvate decarboxylase.
Li H; Jordan F
Biochemistry; 1999 Aug; 38(31):10004-12. PubMed ID: 10433707
[TBL] [Abstract][Full Text] [Related]
20. Altering substrate specificity of phosphatidylcholine-preferring phospholipase C of Bacillus cereus by random mutagenesis of the headgroup binding site.
Antikainen NM; Hergenrother PJ; Harris MM; Corbett W; Martin SF
Biochemistry; 2003 Feb; 42(6):1603-10. PubMed ID: 12578373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
